1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with epiyangambin in 6 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (epiyangambin) | Trials (epiyangambin) | Recent Studies (post-2010) (epiyangambin) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 18 | 0 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbosa-Filho, JM; Bozza, PT; Castro-Faria-Neto, HC; Cruz, HN; Martins, MA; Noel, F; Silva, CL; Thomas, G; Tibiriçá, EV; Violante, FA | 1 |
| Bozza, PT; Castro-Faria-Neto, HC; Cordeiro, RS; Cruz, HN; de Queiroz-Paulo, M; Kaplan, MA; Martins, MA; Silva, PM | 1 |
| Barbosa-Filho, JM; Barreto, EO; Cordeiro, RS; de Silva, PM; Diaz, BL; Lima, MC; Martins, MA; Pereira, AP; Serra, MF | 1 |
| Barbosa-Filho, JM; Castro-Faria-Neto, HC; Cordeiro, RS; Herbert, JM; Tibiriça, E | 1 |
| Aimbire, F; Cailleaux, S; Cordeiro, RS; Lopes-Martins, RA; Tibiriçá, E | 1 |
| Tibiriçá, E | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and epiyangambin
| Article | Year |
|---|---|
Cardiovascular properties of yangambin, a lignan isolated from Brazilian plants.
Topics: Anaphylaxis; Animals; Blood Platelets; Cardiovascular Agents; Furans; Hemodynamics; In Vitro Techniques; Lignans; Plant Extracts; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock, Septic; Stereoisomerism | 2001 |
5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and epiyangambin
| Article | Year |
|---|---|
Yangambin: a new naturally-occurring platelet-activating factor receptor antagonist: binding and in vitro functional studies.
Topics: Animals; Chemotaxis, Leukocyte; Furans; Lignans; Neutrophils; Plants; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1995 |
Pharmacological profile of epiyangambin: a furofuran lignan with PAF antagonist activity.
Topics: Animals; Furans; Lignans; Lignin; Male; Molecular Structure; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rabbits; Rats; Rats, Wistar; Thrombocytopenia | 1993 |
Anti-allergic properties of the natural PAF antagonist yangambin.
Topics: Animals; Anti-Allergic Agents; Eosinophils; Female; Furans; Leukocytosis; Lignans; Male; Neutrophils; Plant Extracts; Platelet Activating Factor; Pleurisy; Rats; Rats, Wistar; Thrombocytopenia | 1997 |
Pharmacological evidence for the putative existence of two different subtypes of PAF receptors on platelets and leukocytes; studies with yangambin.
Topics: Animals; Blood Platelets; Furans; Guinea Pigs; Humans; Interleukin-1; Interleukin-6; Kinetics; Leukocytes; Leukopenia; Lignans; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Respiratory Burst; Thiazoles; Thrombocytopenia; Tumor Necrosis Factor-alpha | 1997 |
Involvement of platelet-activating factor in the modulation of vascular tone in the isolated perfused rabbit kidney.
Topics: Animals; Azepines; Dinoprost; Enzyme Inhibitors; Female; Furans; In Vitro Techniques; Kidney; Lignans; Male; Muscle Tonus; Muscle, Smooth, Vascular; Norepinephrine; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Aggregation Inhibitors; Quinacrine; Rabbits; Renal Circulation; Triazoles; Vasoconstrictor Agents | 1999 |